Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status

By Ruiz P.   Hao L.   Zucker K.   Zacharievich N.   Viciana A.L.   Shenkin M.   Miller J.  

Transplant Immunology, Vol. 5, Iss. 2, 1997-06 ,pp. : 152-161

Elsevier

Access to resources Recommend Favorite

Decreased Dipeptidyl Peptidase IV Enzyme Activity of Plasma Soluble CD26 and Its Inverse Correlation with HIV-1 RNA in HIV-1 Infected Individuals

By Hosono O.   Homma T.   Kobayashi H.   Munakata Y.   Nojima Y.   Iwamoto A.   Morimoto C.  

Clinical Immunology, Vol. 91, Iss. 3, 1999-06 ,pp. : 283-295

Academic Press

Access to resources Recommend Favorite

CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response

By Iwata S.  

International Immunology, Vol. 11, Iss. 3, 1999-03 ,pp. : 417-426

Oxford University Press

Access to resources Recommend Favorite

Altered functional responsiveness of thymocyte subsets from CD3δ-deficient mice to TCR-CD3 engagement

By Kappes D.  

International Immunology, Vol. 10, Iss. 10, 1998-10 ,pp. : 1481-1490

Oxford University Press

Access to resources Recommend Favorite

Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: effects on humoral immunity

By Korom S.   De Meester I.   Schmidbauer G.   Pratschke J.   Brendel M.D.   Durinx C.   Schwemmle K.   Haemers A.   Scharpe S.   Kupiec-Weglinski J.W.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 778-778

Elsevier

Access to resources Recommend Favorite